Primary record
BENZOIC ACID, 4-((1E)-2-(((4-CHLOROPHENYL)METHYL)SULFONYL)ETHENYL)-, SODIUM SALT (1:1)
- 库存
- 3,824 克
- 纯度
- 99.7 %
- CAS
- 922139-31-9
化合物标识与属性
- CAS
- 922139-31-9
- PubChem CID
- 23668369
- SMILES
- C1=CC(=CC=C1CS(=O)(=O)/C=C/C2=CC=C(C=C2)C(=O)[O-])Cl.[Na+]
- Canonical SMILES
- O=C([O-])c1ccc(/C=C/S(=O)(=O)Cc2ccc(Cl)cc2)cc1.[Na+]
名称与同义词
- Recilisib sodium
- Ex-Rad
- Recilisib (sodium)
- Recilisib sodium [USAN]
- ON-01210 SODIUM
- Recilisib sodium (USAN)
- Recilisib sodium [USAN
- UNII-1068SXU525
- RefChem:178714
- ON 01210.Na
- ON-01210.Na
- D02ESL
- ON-01210 sodium salt
- 922139-31-9
- ON 01210. Na
- 1068SXU525
- RECILISIB SODIUM [WHO-DD]
- 4-Carboxystyryl-4-chlorobenzylsulfone
- SCHEMBL1195545
- CHEMBL2219410
- DTXSID101336108
- GLXC-10336
- EX-A2907
- (E)-4-carboxystyryl-4-chlorobenzylsulfone, sodium salt
- HY-101625A
- DA-77383
- ON-01210.Na (oral, radiation sickness)
- CS-0083716
- sodium;4-[(E)-2-[(4-chlorophenyl)methylsulfonyl]ethenyl]benzoate
- D10376
- H37512
- ON-01210.Na (oral, radiation sickness), Onconova
- Q5419119
- sodium (E)-4-(2-((4-chlorobenzyl)sulfonyl)vinyl)benzoate
- Tyrosine kinase inhibitor (radiation protection), Onconova
- ON-01210.Na (sc, radiation sickness), Onconova Therapeutics
- SODIUM 4-((1E)-2-(((4-CHLOROPHENYL)METHYL)SULFONYL(ETHENYL)BENZOATE
- BENZOIC ACID, 4-((1E)-2-(((4-CHLOROPHENYL)METHYL)SULFONYL)ETHENYL)-, SODIUM SALT (1:1)
- Benzoic acid, 4-[(1E)-2-[[(4-chlorophenyl)methyl]sulfonyl]ethenyl]-, sodium salt (1:1)
- 334969-03-8